2025-04-08 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**0. Summary Statistics:**

Colgate-Palmolive Co (CL) is a consumer staples company producing and selling household and personal care products globally.  The company's cumulative return significantly lags the S&P 500 (VOO). While recent earnings show stability, the stock's valuation and performance warrant further investigation.

**1. Performance Comparison:**

* **CL Cumulative Return:** 31.40%
* **VOO (S&P 500) Cumulative Return:** 73.15%
* **Return Difference:** -41.7%
* **Relative Divergence:** 42.0% (This indicates CL's underperformance relative to the S&P 500 lies in the lower 42nd percentile of historical divergence.)

The provided data shows Colgate-Palmolive significantly underperformed the S&P 500 over the analyzed period.  The negative alpha values in some periods suggest the stock's return was less than expected, given its beta (market risk exposure).

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 14.0% | 4.8% | -16.0% | 0.2 | 51.5 |
| 2016-2018  | -12.0% | 8.5% | -30.0% | 0.1 | 41.6 |
| 2017-2019  | 9.0% | 8.5% | -21.0% | 0.0 | 49.4 |
| 2018-2020  | 25.0% | 8.5% | -5.0% | 0.7 | 62.8 |
| 2019-2021  | 35.0% | 8.3% | -39.0% | 1.1 | 64.1 |
| 2020-2022  | 5.0% | 58.7% | -4.0% | 1.1 | 60.6 |
| 2021-2023  | -2.0% | 58.7% | -23.0% | 1.1 | 62.9 |
| 2022-2024  | 7.0% | 58.7% | -12.0% | 1.1 | 73.3 |
| 2023-2025  | 19.0% | 8.8% | 5.0% | 0.6 | 72.3 |

The fluctuating beta suggests varying sensitivity to market movements over the years.  Negative alpha values across multiple periods indicate underperformance compared to the market benchmark.

**2. Recent Price Movement:**

* **Closing Price:** $89.19
* **Previous Close:** $91.66
* **5-Day Moving Average:** $92.86
* **20-Day Moving Average:** $91.65
* **60-Day Moving Average:** $89.85

The price is below all three moving averages, indicating a potential downtrend. The recent price drop of $2.69 is noteworthy.

**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4792 (High Risk)
* **RSI:** 49.15 (Near neutral; neither overbought nor oversold)
* **PPO:** -0.177 (Suggests bearish momentum)
* **20-Day Relative Divergence Change:** +14.6% (Short-term upward movement)
* **Expected Return:** -64.1% (This is a highly negative number and needs further clarification on its calculation methodology. It likely reflects the potential for significant underperformance against the S&P 500 in the long term).

The high MRI suggests high market risk. The negative PPO and the relatively low RSI signal bearish momentum.  The 20-day relative divergence suggests short-term upward movement, however, conflicting signals warrant cautiousness.

**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2024-10-25 | $0.9 | $5.03B        |
| 2024-07-26 | $0.89 | $5.06B        |
| 2024-04-26 | $0.83 | $5.07B        |
| 2023-10-27 | $0.86 | $4.92B        |
| 2024-10-25 | $0.86 | $4.92B        | *(Duplicate entry)*


Earnings show slight fluctuations, but overall, revenue remains relatively stable.  Note a duplicate entry exists in the data.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30%       |
| 2024-09-30 | $5.03B | 61.08%       |
| 2024-06-30 | $5.06B | 60.62%       |
| 2024-03-31 | $5.07B | 60.00%       |
| 2023-12-31 | $4.95B | 59.60%       |

Revenue is relatively consistent. Profit margins show slight fluctuation but stay above 60% for the majority of the period.


**Capital and Profitability:**

| Quarter | Equity | ROE        |
|---------|---------|-------------|
| 2024-12-31 | $0.21B | 348.58%     |
| 2024-09-30 | $0.43B | 169.43%     |
| 2024-06-30 | $0.12B | 594.31%     |
| 2024-03-31 | $0.23B | 296.96%     |
| 2023-12-31 | $0.61B | 117.90%     |

ROE is highly volatile.  The extreme values warrant careful examination of the underlying accounting methods and potential one-time effects.

**6. Overall Analysis:**

Colgate-Palmolive's consistent revenue and relatively high profit margins are positive. However, the stock's significant underperformance relative to the S&P 500, indicated by the negative alpha and large return difference, raises concerns. The volatile ROE and the high market risk indicator add to the uncertainty.  While recent earnings are stable, the bearish technical indicators suggest caution.  The extremely negative expected return (-64.1%) needs further investigation to understand its calculation and implications.  Further analysis, including valuation metrics and a deeper dive into the financial statements, is necessary before making any investment decision.  The data provided suggests a bearish outlook on CL at the present time.
